Literature DB >> 16638501

Utility of multimodal evoked potentials study in neurofibromatosis type 1 of childhood.

Angelo Ammendola1, Gianluca Ciccone, Eduardo Ammendola.   

Abstract

A group of 21 children affected by neurofibromatosis type 1 has been investigated with the aim of studying multimodal (visual, brainstem auditory, and somatosensory) evoked potentials and their correlations with neurologic, electroencephalographic, and cranial magnetic resonance imaging. In the present series, cranial magnetic resonance imaging and evoked potentials were the most frequently abnormal instrumental tests. In approximately two thirds of the cases at least one of the evoked potentials (particularly visual and auditory evoked potentials) was compromised, always without clinical signs of related sensory (visual, auditory, and somatosensory) pathway pathology and sometimes in the absence of magnetic resonance imaging signs of central nervous system involvement. This study indicates that in patients with neurofibromatosis type 1, multimodal evoked potentials are useful and should be part of the diagnostic protocol of encephalic lesions together with magnetic resonance imaging. The use of both methods could aid in early detection of central nervous system dysfunction in both the initial evaluation of disease and its follow-up.

Entities:  

Mesh:

Year:  2006        PMID: 16638501     DOI: 10.1016/j.pediatrneurol.2005.06.013

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  5 in total

Review 1.  Role of visual evoked potentials in the assessment and management of optic pathway gliomas in children.

Authors:  C Van Mierlo; W Spileers; E Legius; I Casteels; C Cassiman
Journal:  Doc Ophthalmol       Date:  2013-07-25       Impact factor: 2.379

2.  Central and peripheral steady-state visual evoked potentials in children with optic pathway gliomas.

Authors:  Sarah Zakaib Rassi; Luis H Ospina; Ariane Bochereau; Yvan Samson; Sébastien Perreault; Dave Saint-Amour
Journal:  Doc Ophthalmol       Date:  2019-06-26       Impact factor: 2.379

3.  Visual function assessed by visually evoked potentials in optic pathway low-grade gliomas with and without neurofibromatosis type 1.

Authors:  Patrícia de Freitas Dotto; Adriana Berezovsky; Andrea Maria Cappellano; Nasjla Saba da Silva; Paula Yuri Sacai; Frederico Adolfo B Silva; Arthur Gustavo Fernandes; Daniel Martins Rocha; Solange Rios Salomão
Journal:  Doc Ophthalmol       Date:  2018-05-15       Impact factor: 2.379

Review 4.  Electrophysiological and Behavioral Evidence for Hyper- and Hyposensitivity in Rare Genetic Syndromes Associated with Autism.

Authors:  Anastasia Neklyudova; Kirill Smirnov; Anna Rebreikina; Olga Martynova; Olga Sysoeva
Journal:  Genes (Basel)       Date:  2022-04-11       Impact factor: 4.141

5.  Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1.

Authors:  Gary Rance; Julien Zanin; Alice Maier; Donella Chisari; Kristina M Haebich; Kathryn N North; Gabriel Dabscheck; Marc L Seal; Martin B Delatycki; Jonathan M Payne
Journal:  JAMA Netw Open       Date:  2021-12-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.